An observational study in Acute Disease, sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. Recruiting at 1 site in Spain. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2025-12-05.
Sponsored by Consorci Sanitari de l'Alt Penedès i Garraf · Observational
The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission
Patients aged 75 years or older who are admitted to an ICU
Exclusion Criteria:
Participants who meet any of the following exclusion criteria may not be included in the study:
-Death within the first 24 hours of ICU admission.
This group has a positive result for NECPAL scale
Mortality
Patients who dye at 90-day from ICU admission
Time frame: From baseline to 90-day
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Consorci Sanitari de l'Alt Penedès i Garraf